High-risk Prostate Cancer
Oncology·MeSH: Prostatic Neoplasms
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for High-risk Prostate Cancer?
BioSniper tracks 2 drugs in development for High-risk Prostate Cancer across 1 company.
How many clinical trials target High-risk Prostate Cancer?
There are 3 clinical trials targeting High-risk Prostate Cancer tracked by BioSniper.
What is the prevalence of High-risk Prostate Cancer?
The estimated prevalence of High-risk Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into High-risk Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis